PACS Group, Inc. (PACS) financial statements and ratios from SEC XBRL: revenue $5.7B (TTM), net margin 3.6%, revenue growth 9.1% YoY, P/E 23.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $5.29B |
| Revenue (TTM) | $5.7B |
| Net Margin | 3.6% |
| Operating Margin (TTM) | 8.5% |
| Revenue Growth (YoY) | 9.1% |
| EPS Growth (YoY) | 45.5% |
| P/E Ratio | 23.4 |
| EV / EBITDA | 15.8 |
| Price / Book | 6.23 |
| Price / Sales | 1.24 |
| Altman Z-Score | 2.12 (grey) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
PACS overview · PACS earnings · PACS KPIs · PACS documents · PACS ownership · PACS peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.